STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

STRATEC Biomedical AG 

27.01.2012 20:09

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------


1st voting rights announcement

Threadneedle Investment Funds ICVC, London, UK, has notified us pursuant to
§ 21 sec. 1 WpHG on 25 January 2012, that on 19 January 2012 the share of
voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN:
DE0007289001, fell below the threshold of 5% and that the percentage of
voting rights on that day amounted to 4.71% (550,051 shares). These voting
rights are directly held by Threadneedle Investment Funds ICVC.


2nd voting rights anouncement

Threadneedle Investment Services Limited, London, UK, has notified us
pursuant to § 21 sec. 1 WpHG on 25 January 2012, that on 19 January 2012
the share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany,
ISIN: DE0007289001, fell below the threshold of 5% and that the percentage
of voting rights on that day amounted to 4.71% (550,051 shares). Pursuant
to § 22 para. 1 sent. 1 No. 6 WpHG, these voting rights are in their
entirety attributable to Threadneedle Investment Services Limited, London,
UK. These voting rights are directly held by Threadneedle Investment Funds
ICVC.



27.01.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      STRATEC Biomedical AG
              Gewerbestr. 37
              75217 Birkenfeld
              Germany
Internet:     www.stratec.com
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------